The Centers for Disease Control and Prevention’s independent Advisory Committee on Immunization Practices today recommended Pfizer’s COVID-19 vaccine be administered for children ages five through 11. The 14-0 vote paves the way for the first doses to be administered to that age group, pending approval by CDC Director Rochelle Walensky, M.D. Across its deliberations, the committee urged thorough, clear communications with families of potential-but-rare side effects, including myocarditis, with information on symptoms and where to seek medical care.

Related News Articles

Headline
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Etiam ac tortor pulvinar massa vehicula laoreet a sit amet magna. Pellentesque quis molestie justo, at…
Headline
The Centers for Medicare & Medicaid Services today released updated interpretive guidance on its Omnibus COVID-19 Health Care Staff Vaccination…
Blog
To help hospitals and health system leaders stay up-to-date on all of the legal developments related to vaccine mandates, the AHA has developed a blog…
Headline
Leaders from the AHA and the American College of Obstetricians and Gynecologists, hospital leaders, clinicians and experts from the Centers for Disease Control…
Headline
A new AHA video is tackling prominent myths about COVID-19 and its vaccines, providing the public with the facts they need to make sound health decisions…
Headline
In addition to the seven new 2022 ICD-10 procedure codes announced in November, the Centers for Medicare & Medicaid Services on April 1 will implement…